In the past 40 years, the rates of asthma and allergies have increased dramatically in westernized countries (>30% of school age children in the US, Great Britain, New Zealand and Australia currently have asthma). The mechanism(s) underlying this increase is unknown. However, this staggering increase in the incidence of asthma in this time frame indicates that factors beyond genetics play a major role in the development of the disease. Numerous epidemiologic studies in humans have shown a correlation between antibiotic use or altered fecal microflora and the development of allergies. The hypothesis of this proposal is that the microflora plays a central role in maintaining mucosal tolerance to inhaled/swallowed antigens, which prevents the development of over-exuberant inflammatory responses to these antigens (i. e. allergies). Thus, changes in microflora populations, including increased growth of fungal microflora (Candida), decrease mucosal tolerance resulting in the development of allergic responses to inhaled allergens. Antibiotics and diet have a major impact on the composition of the microflora. We have generated an animal model to test this hypothesis and our preliminary studies with this model support the concept that altered microflora can be a potential mechanism underlying the development of allergic airway disease.
The specific aims of this proposal are the following: 1. To analyze the dynamics of microbiota reconstitution that occurs following the cessation of antibiotics in the presence and absence of Candida in the gastrointestinal tract. 2. To determine the effect of different Candida species and isolates on disrupting mucosal tolerance and to determine the duration of defective mucosal tolerance. 3. To analyze the contribution of Candida """"""""virulence"""""""" factors in disrupting mucosal tolerance in mice during Candida persistence in the Gl tract. 4. To determine whether antibiotic-induced microbiota disruption alters the development of antigen-specific regulatory T cell responses for the lungs. These studies will provide the basic science foundation for future studies in humans for understanding how and why manipulation of the microflora (by diet or probiotics) can alter or prevent allergies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI064479-01
Application #
6907647
Study Section
Special Emphasis Panel (ZRG1-IDM-J (02))
Program Officer
Duncan, Rory A
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
1
Fiscal Year
2005
Total Cost
$377,412
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Huffnagle, Gary B; Noverr, Mairi C (2013) The emerging world of the fungal microbiome. Trends Microbiol 21:334-41
Murdock, Benjamin J; Falkowski, Nicole R; Shreiner, Andrew B et al. (2012) Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. Infect Immun 80:1424-36
Gillilland 3rd, Merritt G; Erb-Downward, John R; Bassis, Christine M et al. (2012) Ecological succession of bacterial communities during conventionalization of germ-free mice. Appl Environ Microbiol 78:2359-66
Han, Meilan K; Huang, Yvonne J; Lipuma, John J et al. (2012) Significance of the microbiome in obstructive lung disease. Thorax 67:456-63
Shreiner, Andrew B; Murdock, Benjamin J; Sadighi Akha, Amir A et al. (2012) Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10. Infect Immun 80:388-97
Mason, Katie L; Erb Downward, John R; Falkowski, Nicole R et al. (2012) Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun 80:150-8
Murdock, Benjamin J; Shreiner, Andrew B; McDonald, Roderick A et al. (2011) Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun 79:125-35
Mason, Katie L; Huffnagle, Gary B (2009) Control of mucosal polymicrobial populations by innate immunity. Cell Microbiol 11:1297-305
Shreiner, Andrew; Huffnagle, Gary B; Noverr, Mairi C (2008) The ""Microflora Hypothesis"" of allergic disease. Adv Exp Med Biol 635:113-34
Milam, Jami E; Herring-Palmer, Amy C; Pandrangi, Raj et al. (2007) Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector. Infect Immun 75:4951-8

Showing the most recent 10 out of 12 publications